Prosecution Insights
Last updated: August 06, 2026

Korus Patent, LLC

5 pending office actions • 5 clients • 5 examiners • 4 art units • 0 of 5 (0%) have an AI response strategy ready

Quality Metrics (n=856 apps, methodology: how we score firms)

79.2%
Allowance Rate
n=856
+0.46σ
Allowance Rate (norm)
n=856
2.1
OAs to Allowance
n=614
-0.76σ
OAs to Allow (norm)
n=614
765 days
Time to Allowance
n=614
+9.5pp
Interview Lift
n=856
14.1%
RCE Rate
n=856
1.9%
Appeal Rate
n=856

Rejection Performance (% of received rejections ultimately overcome)

64.6%
§101 Overcome
n=82
71.4%
§102 Overcome
n=241
71.7%
§103 Overcome
n=441
72.8%
§112 Overcome
n=394

Specialization & Scale

G06F, G06Q, H04R
Top CPC Subclasses
9%
Top-3 CPC Share
n=856
1
Practitioners
n=856
856.0
Apps / Practitioner
n=856

Portfolio Summary

5
Total Pending OAs
5
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (80%)
1
Medium (20%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§103 only1 (20%)
Multi-statute (no §101)3 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
40% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
40% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SEGED, NEBYATE SAMUEL 1 29.0% +45.1%
TEJANI, ANKIT D 1 81.0% +16.9%
SHOMER, ISAAC 1 63.3% +30.3%
JENNISON, BRIAN W 1 71.8% +22.1%
DARRIGRAND, EMILY ANN 1

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18169318 COFFEE MAKER JENNISON, BRIAN W 37d overdue
18280178 PHARMACEUTICAL COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS THROUGH INFLAMMATION AMELIORATION OF HUMAN DERMAL PAPILLA CELLS AND PERIPHERAL CELLS AND INHIBITION OF 5A-REDUCTASE EXPRESSION SHOMER, ISAAC 24d overdue
18624742 MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR TEJANI, ANKIT D 26d
18795800 PLASMA AIR PURIFYING APPARATUS SEGED, NEBYATE SAMUEL
17909866 METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE DARRIGRAND, EMILY ANN

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18169318 COFFEE MAKER JENNISON, BRIAN W 37d overdue
18280178 PHARMACEUTICAL COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS THROUGH INFLAMMATION AMELIORATION OF HUMAN DERMAL PAPILLA CELLS AND PERIPHERAL CELLS AND INHIBITION OF 5A-REDUCTASE EXPRESSION SHOMER, ISAAC 24d overdue
18624742 MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR TEJANI, ANKIT D 26d
18795800 PLASMA AIR PURIFYING APPARATUS SEGED, NEBYATE SAMUEL

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
37961
16121
37611
16861

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18795800 PLASMA AIR PURIFYING APPARATUS Junsys Co., Ltd. SEGED, NEBYATE SAMUEL §103 Non-Final OA Pending Aug 06, 2024
18624742 MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR Techcord Co., Ltd. TEJANI, ANKIT D 3796 §102§103Other Non-Final OA 26d Pending Apr 02, 2024
18280178 PHARMACEUTICAL COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS THROUGH INFLAMMATION AMELIORATION OF HUMAN DERMAL PAPILLA CELLS AND PERIPHERAL CELLS AND INHIBITION OF 5A-REDUCTASE EXPRESSION Jong Moon Jeong SHOMER, ISAAC 1612 §103§112 Non-Final OA 24d overdue Pending Sep 01, 2023
18169318 COFFEE MAKER Hugh Inc. JENNISON, BRIAN W 3761 §103§112 Non-Final OA 37d overdue Pending Feb 15, 2023
17909866 METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE Theragen Bio Co., Ltd. DARRIGRAND, EMILY ANN 1686 §101§103§112 Non-Final OA Pending Sep 07, 2022

Managing Korus Patent, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month